Middle East & Africa Medical Second Opinion Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The medical second opinion market in the Middle East and Africa is projected to grow significantly, reaching approximately US$ 215.90 million by 2031, up from US$ 111.86 million in 2023. This growth represents a compound annual growth rate (CAGR) of 8.6% from 2023 to 2031.

Executive Summary and Market Analysis

The Middle East and Africa region includes countries such as the United Arab Emirates (UAE), Saudi Arabia, South Africa, and other nations in the area. The market is anticipated to expand due to several factors, including rising healthcare expenditures, the introduction of improved treatment options, and the increasing prevalence of chronic diseases.

Market Segmentation Analysis

The medical second opinion market is categorized based on medical conditions and service providers.

By Condition: The market is segmented into various categories, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.
By Service Provider: The market is also divided into hospitals, health insurance companies, and online services, with hospitals holding the largest share in 2023.

Market Outlook

The integration of medical services with digital platforms is enhancing the popularity of digital consultations. This trend allows patients to obtain second opinions without needing to visit healthcare facilities, offering convenience and improving patient experiences while managing costs effectively. Digital platforms enable consultations from remote areas, increasing access to medical experts. Collaborations between software developers and healthcare institutions are driving the digital transformation of medical consulting services. For instance, in October 2021, Cigna Health Plan announced an expansion of its virtual care services, which includes digital-first primary care and other specialties. This digital shift is expected to significantly boost the medical second opinion market in the coming years.

Country Insights

The market analysis by country reveals that Saudi Arabia, South Africa, and the UAE are key players, with Saudi Arabia holding the largest market share in 2023.

Saudi Arabia is witnessing a sharp rise in cancer cases, with projections indicating an increase from 27,885 new cases in 2020 to 60,429 by 2040. Additionally, the prevalence of neurological disorders, such as Parkinson's disease, is notable, with a rate of 27 per 100,000 people. The demographic shift in Saudi Arabia, with a growing elderly population, further exacerbates the risk of chronic diseases, necessitating medical second opinions to avoid misdiagnoses.

The International Medical Center (IMC) in Saudi Arabia has partnered with the Mayo Clinic Care Network, allowing healthcare professionals to consult with Mayo Clinic doctors for second opinions, thereby alleviating patient anxiety. Telemedicine platforms, such as MyUSADr, are also gaining traction, providing access to US-based specialists for patients in Saudi Arabia seeking second opinions. These developments are likely to support market growth in the region.

Company Profiles

Key players in the Middle East and Africa medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors, among others. These companies are pursuing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase market share.

Product Code: TIPRE00025161

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Middle East & Africa Medical Second Opinion Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Middle East & Africa Medical Second Opinion Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing Emphasis on Better Treatment Outcomes
- 5.1.2 Increasing Preference for Healthcare Cost Optimization
5.2 Market Restraints
- 5.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
5.3 Market Opportunities
- 5.3.1 Rising Collaborations in Telemedicine Technologies
5.4 Future Trends
- 5.4.1 Digitalization of Medical Consulting Services
5.5 Impact of Drivers and Restraints:

6. Medical Second Opinion Market - Middle East & Africa Analysis

6.1 Middle East & Africa Medical Second Opinion Market Revenue (US$ Million), 2021-2031
6.2 Middle East & Africa Medical Second Opinion Market Forecast Analysis

7. Middle East & Africa Medical Second Opinion Market Analysis - by Condition

7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Orthopedic Disorders
- 7.2.1 Overview
- 7.2.2 Orthopedic Disorders: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Cardiac Disorders
- 7.3.1 Overview
- 7.3.2 Cardiac Disorders: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Neurological Disorders
- 7.4.1 Overview
- 7.4.2 Neurological Disorders: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Nephrological Disorders
- 7.5.1 Overview
- 7.5.2 Nephrological Disorders: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Hematological Blood Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Blood Disorders: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.7 COPD
- 7.7.1 Overview
- 7.7.2 COPD: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Organ Transplant
- 7.8.1 Overview
- 7.8.2 Organ Transplant: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Medical Second Opinion Market Analysis - by Service Provider

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Health Insurance Companies
- 8.2.1 Overview
- 8.2.2 Health Insurance Companies: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Online Services
- 8.3.1 Overview
- 8.3.2 Online Services: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Medical Second Opinion Market - Country Analysis

9.1 Middle East & Africa
- 9.1.1 Middle East & Africa Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 Middle East & Africa Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 Saudi Arabia: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.2.1 Saudi Arabia: Middle East & Africa Medical Second Opinion Market Share - by Condition
    - 9.1.1.2.2 Saudi Arabia: Middle East & Africa Medical Second Opinion Market Share - by Service Provider
  - 9.1.1.3 South Africa: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.3.1 South Africa: Middle East & Africa Medical Second Opinion Market Share - by Condition
    - 9.1.1.3.2 South Africa: Middle East & Africa Medical Second Opinion Market Share - by Service Provider
  - 9.1.1.4 United Arab Emirates: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.4.1 United Arab Emirates: Middle East & Africa Medical Second Opinion Market Share - by Condition
    - 9.1.1.4.2 United Arab Emirates: Middle East & Africa Medical Second Opinion Market Share - by Service Provider
  - 9.1.1.5 Rest of Middle East & Africa: Middle East & Africa Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Medical Second Opinion Market Share - by Condition
    - 9.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Medical Second Opinion Market Share - by Service Provider

10. Industry Landscape

10.1 Overview
10.2 Market Initiative
10.3 Partnerships and Collaborations

11. Company Profiles

11.1 Second Opinion International
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Elite Medical Services
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 The Cigna Group
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Helsana
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 WorldCare
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Vidal Health Insurance TPA Pvt Ltd
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 2nd.MD
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Axa SA
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Teladoc Health Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Included Health, Inc.
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 Royal Doctors
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments

12. Appendix

12.1 About Us
12.2 List of Abbreviations